By: ICN Bureau
Last updated : November 02, 2026 10:15 am
Overcapacity & geopolitical turmoil force shift
The global chemical industry is entering 2027 with little certainty of a broad-based recovery, as structural overcapacity, uneven demand, geopolitical tensions and regional cost disparities continue to squeeze profitability.
The challenge for chemical companies is no longer simply to weather the downturn or wait for the next demand cycle. It is to find ways to create value despite persistent uncertainty.
The industry is consequently facing a strategic reset, with companies reassessing their portfolios, restructuring supply chains, redirecting investments and accelerating the adoption of artificial intelligence (AI) and digital technologies.
The shift is also changing how chemical companies compete. Rather than relying solely on production volumes and economies of scale, businesses are increasingly looking towards specialty products, application-specific solutions, technical services and closer customer partnerships.
This transition will require companies to balance the cost discipline of commodity businesses with the innovation, customer intimacy and technical expertise needed to compete in specialty markets.
Five major trends are expected to shape the industry's strategic direction in 2027.
1. Supply chain disruptions force chemical companies to rethink global networks
Geopolitical tensions and extreme weather events have exposed the vulnerabilities of global chemical supply chains, forcing companies to reconsider their dependence on concentrated sources of energy, feedstocks and critical raw materials.
Disruptions in 2026 affected Gulf-linked supplies of energy and key chemicals, including polypropylene, methanol and ammonia. Companies responded by shifting production to unaffected regions and rerouting cargoes, driving up freight costs and extending delivery timelines.
Shipping routes also came under pressure. Increased traffic through the Panama Canal was followed by lower rainfall and restrictions on transit capacity, adding to delays. Low water levels on the Rhine and the continuing Russia-Ukraine war further complicated logistics.
The disruptions have pushed supply chain resilience beyond the traditional procurement agenda. Supply continuity now has direct implications for production planning, customer relationships, working capital, investment decisions and profitability.
The 2027 outlook: Chemical companies are expected to move away from dependence on a single optimized global supply network towards more flexible supply, inventory and transportation arrangements.
Commodity producers could increasingly explore dual sourcing, regional production, tolling arrangements and alternative logistics routes. Specialty chemical and industrial gas companies, meanwhile, may prioritize localized production and infrastructure closer to customers.
Investment in localized storage, supply chain visibility and scenario-based planning is also likely to gain importance as companies seek to reduce exposure to geopolitical flashpoints and concentrated supplier networks.
The priority will no longer be simply finding the cheapest supply route, but ensuring that companies have viable alternatives when disruption strikes.
2. Plant closures and portfolio exits give way to strategic reinvestment
After a record number of plant-closure announcements in 2025, chemical companies continued to restructure their portfolios in 2026, increasingly shifting from announcing capacity cuts to implementing them.
Divestitures, carve-outs and proposed spin-offs also gathered momentum as companies sought to separate commodity operations from higher-value businesses.
Mergers and acquisitions became more selective, with buyers focusing on assets offering competitive advantages in feedstock access, technology, scale, integration and downstream markets.
Investment patterns remained sharply divided by geography and product segment. China continued to add capacity, while investment activity in Europe remained relatively subdued. Capital increasingly flowed towards electronics, advanced materials and competitively positioned US assets.
The underlying problem, however, remains unresolved: structural oversupply, particularly in commodity chemicals exposed to China's expanding production capacity.
While disruptions in the Middle East have temporarily altered utilization rates and pricing in favour of some producers, they have done little to address the industry's excess capacity.
The emerging strategy is increasingly clear: exit businesses where competitive advantages are difficult to defend and redirect capital towards assets capable of delivering sustainable returns.
The 2027 outlook: Plant closures, portfolio separations and asset sales are expected to continue. M&A activity will likely remain selective, with buyers prioritizing businesses that offer structural cost advantages, stronger market positions or strategic integration benefits.
Due diligence is also expected to become more complex, with greater scrutiny of tariffs, trade restrictions, customer relationships, feedstock security and regulatory exposure.
But cutting capacity alone will not create long-term value. Companies will need to channel the savings into stronger assets, new technologies and high-growth businesses.
Partnerships and selective capital commitments could become increasingly important, particularly for companies that have identified investment opportunities but lack the financial or managerial capacity to pursue them independently.
3. Chemical companies shift from chasing volumes to targeting high-growth markets
Weakness across traditional end markets is pushing chemical companies to look beyond conventional volume-driven growth and target sectors with stronger structural demand.
In 2026, advanced manufacturing emerged as an important growth engine. Semiconductor-related gases, electronic materials, high-purity water and fabrication infrastructure supported demand, while aerospace and space applications boosted requirements for specialty materials, helium and hydrogen.
Biopharma, cleanroom protection, data-centre thermal management and electric vehicle battery applications also created new opportunities.
At the same time, some companies became more cautious about large standalone hydrogen and energy-transition projects, increasingly favouring investments backed by firm customer commitments and clearer returns.
The shift is significant because more than 80% of basic and specialty chemicals are purchased directly by industrial sectors. The industry's growth prospects are therefore closely tied to where industrial customers are directing their investments.
The 2027 outlook: Semiconductor fabrication plants and advanced packaging facilities are expected to remain major investment destinations, creating opportunities in high-purity gases, electronic chemicals, process-water treatment, hydrogen and on-site supply systems.
Chemical companies could increasingly expand production capacity near major customer clusters in North America and Asia.
Industrial gases offer a clear example of this opportunity. Demand is spread across electronics, manufacturing, energy, metallurgy and healthcare. High-purity gases and other specification-critical inputs can command premium economics because stringent qualification requirements and technical capabilities make substitution difficult.
The broader strategy is to move away from undifferentiated commodity volumes and towards high-value, application-specific markets.
However, success will depend on more than supplying materials. Companies will need to combine chemical expertise with infrastructure, application engineering and lifecycle services to secure stronger customer relationships.
4. AI and technical expertise turn chemical suppliers into strategic partners
The traditional business of selling chemicals by volume is giving way to a more sophisticated model in which customers increasingly value reliability, technical support, supply continuity and solutions to specific operational challenges.
Supply chain risks and increasingly demanding applications are accelerating this shift, pushing suppliers to offer more than products.
Artificial intelligence is emerging as a key enabler. Chemical companies are using AI to identify unmet customer needs, accelerate formulation development and optimize plant operations.
AI spending in the chemical industry is projected to rise from US$1.4 billion in 2024 to US$8 billion in 2029.
The commercial opportunity lies in applying technical expertise to customer processes rather than simply increasing product sales.
In aerospace, preformed 3D-printed sealants can reduce manual installation time. In coatings, digital formulation tools can help customers compare additives, troubleshoot defects and access regulatory information.
AI-enabled recipe adjustments in colour and fragrance can also reduce trial-and-error cycles, incorporate consumer feedback and improve right-first-time performance.
The 2027 outlook: Chemical suppliers are expected to increasingly monetize their technical expertise through deeper customer partnerships, long-term supply arrangements and AI-enabled services.
Companies could build dedicated partnership models linking commercial teams with scientists and plant operators, allowing them to identify customer challenges and develop solutions faster.
The concept of going "beyond the molecule" is likely to gain traction, with trusted supply, application expertise, digital tools and AI-enabled collaboration becoming integral to the commercial offering.
For chemical companies, the competitive advantage will increasingly come not just from what they manufacture, but from how effectively they help customers improve performance.
5. Chemical companies move beyond restructuring to reinvent their operating models
Cost-cutting, workforce reductions and plant closures may address immediate financial pressures, but they are unlikely to deliver the structural transformation the chemical industry needs.
In 2026, some companies began shifting their focus towards redesigning how their businesses operate, combining portfolio restructuring with clearer decision-making structures, streamlined processes, shared services, enterprise resource planning modernization and smarter operations.
The objective is moving beyond simply reducing headcount to eliminating duplication, improving accountability and redirecting talent towards higher-value activities.
The challenge is particularly complex because commodity and specialty chemical businesses require fundamentally different operating models.
Commodity operations depend on scale, cost discipline, reliable assets, feedstock advantages and efficient supply chains. Specialty businesses require closer customer engagement, faster innovation, technical expertise and application-specific capabilities.
Managing both within the same enterprise could require a fundamental rethink of commercial strategies, workforce structures and technology investments.
The 2027 outlook: Three priorities are expected to shape this transformation.
1. Workforce and capability redesign: Companies will increasingly look to simplify processes, clarify accountability and expand shared services and global capability centres. Automation, analytics, planning and continuous improvement could replace routine transaction-based activities, while reskilling protects critical engineering, safety, reliability and innovation capabilities.
2. Digital infrastructure and AI-enabled operations: Enterprise resource planning modernization, predictive maintenance, digital twins, automated scheduling and logistics visibility could improve plant and supply chain performance. AI applications in demand forecasting, pricing, supply planning and working capital will become increasingly important, although returns will depend on data quality, implementation capabilities and measurable business outcomes.
3. Integrated value-chain and commercial models: Companies will need to better connect tax, supply chains, enterprise resource planning, transfer pricing, tolling arrangements and legal structures. Customer and market data could also support more effective pricing, production and inventory decisions while creating opportunities for recurring services such as managed dosing, replenishment and digital formulation.
The goal is to build a structurally leaner, faster and more responsive organization rather than relying on repeated rounds of cost-cutting.
Chemical industry's 2027 challenge: Create value without waiting for recovery
The global chemical industry enters 2027 with little indication that a broad-based cyclical recovery will resolve its underlying problems.
Excess capacity, uneven demand, geopolitical instability and regional cost differences are likely to remain defining features of the business environment.
The industry's next phase will therefore be determined less by when demand rebounds and more by how effectively companies make and execute strategic choices.
That means shedding structurally disadvantaged assets, strengthening competitive positions, redirecting capital towards high-value markets, securing supply chain flexibility and accelerating technology adoption.
Resilience, in this environment, will mean more than surviving disruptions. It will require the ability to redirect supply, capital and talent quickly, anticipate customer needs and respond to market shifts with greater agility.
For chemical companies, the message heading into 2027 is clear: waiting for the downturn to end is no longer a strategy. The winners will be those that reinvent their businesses, sharpen their competitive advantages and create value despite the uncertainty.
(By David Yankovitz, Tom Aldred, Robert Kumpf, Kate Hardin, Ashlee Christian)